Trial Profile
A prospective open-label extension study (to study 99784) of gaboxadol in primary insomnia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Jul 2007
Price :
$35
*
At a glance
- Drugs Gaboxadol - Ovid Therapeuticsgaboxadol (Primary)
- Indications Insomnia
- Focus Adverse reactions; Registrational
- 18 Nov 2005 New trial record.